BCIQ Profiles

Company Profile Report
0615 ECP Scenic Biotech
BioCentury & Getty Images

Emerging Company Profile

Scenic: targeting genetic modifiers to suppress disease drivers

Emerging Company Profile: Amsterdam-based Scenic is developing small molecules against genetic modifiers for metabolic and inflammatory rare diseases, cancer

Amsterdam-based Scenic is developing small molecules against genetic modifiers for metabolic and inflammatory rare diseases and cancer. 

Jun 15, 2021 | 5:38 PM GMT

Scenic Biotech is building a compendium of genetic data to identify rare, naturally occurring genetic modifiers

Read the full 732 word article

How to gain access

Continue reading with a
two-week free trial.